Jerusalem Pharmaceuticals Co. Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 10.47 million compared to USD 9.26 million a year ago. Net income was USD 1.31 million compared to USD 0.862628 million a year ago. Basic earnings per share from continuing operations was USD 0.073 compared to USD 0.048 a year ago.